Search
for

    Sort by

    Research 211–240 of 1000+

    1. Safety and Efficacy of the Coadministration of Sildenafil and Finasteride Daehan binyogi jong-yang haksulji · 2018
    2. Autotaxin–lysophosphatidic acid– LPA <sub>3</sub> signaling at the embryo‐epithelial boundary controls decidualization pathways The EMBO Journal · 2017 · 44 citations
    3. Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus Heliyon · 2025
    4. Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2023
    5. US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? European urology open science · 2023
    6. Anabolic-Androgenic Steroids and Cardiometabolic Derangements Cureus · 2021 · 2 citations
    7. Dual deficiency of melatonin and dihydrotestosterone promotes stromal cell damage and mediates prostatitis via the cGAS-STING pathway in sleep-deprived mice Cell communication and signaling · 2024
    8. Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know? Reviews in Endocrine and Metabolic Disorders · 2015 · 111 citations
    9. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms Translational Andrology and Urology · 2016 · 26 citations
    10. Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men Current Geriatrics Reports · 2019 · 2 citations
    11. Acute liver damage due to <i>Serenoa repens</i>: a case report British Journal of Clinical Pharmacology · 2010 · 35 citations
    12. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    13. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    14. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    15. Clinical applications of antiandrogens Journal of Steroid Biochemistry · 1988 · 29 citations
    16. Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships Current Medicinal Chemistry · 2000 · 204 citations
    17. 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report Journal of Advances in Internal Medicine · 2021
    18. 5α-reductase inhibitors/finasteride The Prostate · 1996 · 24 citations
    19. 5alpha-reductase inhibitors/finasteride. PubMed · 1996 · 4 citations
    20. Dihydrotestosterone—a culprit in left ventricular hypertrophy International Journal of Cardiology · 2012 · 4 citations
    21. Finasteride: the first 5 alpha-reductase inhibitor. PubMed · 1993 · 34 citations
    22. 5alpha-reductase: history and clinical importance. PubMed · 2004 · 62 citations
    23. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    24. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. PubMed · 1997 · 7 citations
    25. Dutasteride Drugs · 2008 · 45 citations
    26. Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond Journal of Chemical Crystallography · 2008 · 2 citations
    27. 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia 2024
    28. A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica) Current traditional medicine · 2017 · 8 citations
    29. Androgen receptors and their biology Vitamins and hormones · 2001 · 66 citations
    30. Male androgenetic alopecia (Part II) The Journal of Men's Health & Gender · 2005 · 9 citations